In the News
Research by Joseph Neglia, M.D., M.P.H., Screening, Prevention, Etiology and Cancer Survivorship program, was featured in Health News Digest.
The Masonic Cancer Center was mentioned in a PRNewswire report on Oxis International, Inc. debt restructuring. The report notes that this will pave the way for moving forward with the Phase 1/Phase 2 FDA clinical trial in collaboration with the Masonic Cancer Center, University of Minnesota.
Timothy Church, Ph.D., Screening, Prevention, Etiology and Cancer Survivorship program, will be on the advisory board of a new company that was formed by Illumina to enable early cancer detection via blood-based screening. Read more in Business Wire.
Robert Turesky, Ph.D., Carcinogenesis and Chemoprevention Program, is quoted in a Student Science article about the World Health Organization report on the cancer risk associated with consumption of processed meats.
The Masonic Cancer Center was mentioned in a BPLeader.com story about a cancer auction in Faribault that raises funds for the Eagles Cancer Telethon each January. The telethon raises money for cancer research at Mayo Clinic, Hormel Institute for Cancer Research and the Masonic Cancer Center. This year’s telethon is scheduled for January 16-17.